In spite of the widespread use of chemotherapy and radiotherapy in current-day cancer treatments, the genotoxic stress-induced nuclear NF-κB signaling pathway that leads to NF-κB transactivation is still less defined, than NF-κB activation initiated from cell membrane stimuli (e.g. immune receptors). The gene discussed is NFKB1; the disease is cancer.